AC
ASPX

Andromeda Capital’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Andromeda Capital’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-7,674
Closed -$769K – 41
2015
Q1 		$769K Buy
+7,674
New +$511K 1.16% 22

Andromeda Capital's ASPX Position: Q2 2015 in Review

Andromeda Capital sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 7,674 shares — an estimated $769K sold.

Andromeda Capital first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $769K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Andromeda Capital reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Andromeda Capital sold 7,674 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $769K.
  • Andromeda Capital first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Andromeda Capital's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $769K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Andromeda Capital's 13F filing for Q2 2015, filed 14 Aug 2015.